High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.

The plasmacytoma variant translocation 1 gene (PVT1) plays an oncogenic role in the initiation and progression of multiple cancers. In this study, by using deep-sequencing data and follow-up data in the Cancer Genome Atlas-Uveal melanomas (TCGA-UVM), we assessed the association between the expressio...

Full description

Bibliographic Details
Main Authors: Haiming Xu, Jingwen Gong, Hui Liu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5731763?pdf=render
_version_ 1818668463604891648
author Haiming Xu
Jingwen Gong
Hui Liu
author_facet Haiming Xu
Jingwen Gong
Hui Liu
author_sort Haiming Xu
collection DOAJ
description The plasmacytoma variant translocation 1 gene (PVT1) plays an oncogenic role in the initiation and progression of multiple cancers. In this study, by using deep-sequencing data and follow-up data in the Cancer Genome Atlas-Uveal melanomas (TCGA-UVM), we assessed the association between the expression of PVT1 and clinicopathological characteristics of patients with uveal melanoma, the mechanism of its dysregulation and its prognostic value. Results showed that high PVT1 expression group had a higher proportion of epithelioid cell dominant disease (a more malignant histological subtype than spindle cell dominant disease) and more cases of extrascleral extension (a risk factor for metastasis) compared with the low PVT1 expression group. 61 out of 80 cases (76.3%) of primary uveal melanoma had PVT1 amplification in TCGA-UVM. In addition, PVT1 expression was strongly and negatively correlated with its methylation status (Pearson's r = -0.712, Spearman's r = -0.806). By performing univariate and multivariate analysis, we found that high PVT1 expression was an independent predictor of poor OS in patients with uveal melanoma (HR: 12.015, 95%CI: 1.854-77.876, p = 0.009). Based on these findings, we infer that PVT1 expression is modulated by both DNA amplification and methylation and its expression might serve as a valuable and specific prognostic biomarker in terms of OS in uveal melanoma.
first_indexed 2024-12-17T06:36:43Z
format Article
id doaj.art-3cde98ed459e49f996e910b8238d7e6f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-17T06:36:43Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-3cde98ed459e49f996e910b8238d7e6f2022-12-21T22:00:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011212e018967510.1371/journal.pone.0189675High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.Haiming XuJingwen GongHui LiuThe plasmacytoma variant translocation 1 gene (PVT1) plays an oncogenic role in the initiation and progression of multiple cancers. In this study, by using deep-sequencing data and follow-up data in the Cancer Genome Atlas-Uveal melanomas (TCGA-UVM), we assessed the association between the expression of PVT1 and clinicopathological characteristics of patients with uveal melanoma, the mechanism of its dysregulation and its prognostic value. Results showed that high PVT1 expression group had a higher proportion of epithelioid cell dominant disease (a more malignant histological subtype than spindle cell dominant disease) and more cases of extrascleral extension (a risk factor for metastasis) compared with the low PVT1 expression group. 61 out of 80 cases (76.3%) of primary uveal melanoma had PVT1 amplification in TCGA-UVM. In addition, PVT1 expression was strongly and negatively correlated with its methylation status (Pearson's r = -0.712, Spearman's r = -0.806). By performing univariate and multivariate analysis, we found that high PVT1 expression was an independent predictor of poor OS in patients with uveal melanoma (HR: 12.015, 95%CI: 1.854-77.876, p = 0.009). Based on these findings, we infer that PVT1 expression is modulated by both DNA amplification and methylation and its expression might serve as a valuable and specific prognostic biomarker in terms of OS in uveal melanoma.http://europepmc.org/articles/PMC5731763?pdf=render
spellingShingle Haiming Xu
Jingwen Gong
Hui Liu
High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
PLoS ONE
title High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
title_full High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
title_fullStr High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
title_full_unstemmed High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
title_short High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
title_sort high expression of lncrna pvt1 independently predicts poor overall survival in patients with primary uveal melanoma
url http://europepmc.org/articles/PMC5731763?pdf=render
work_keys_str_mv AT haimingxu highexpressionoflncrnapvt1independentlypredictspooroverallsurvivalinpatientswithprimaryuvealmelanoma
AT jingwengong highexpressionoflncrnapvt1independentlypredictspooroverallsurvivalinpatientswithprimaryuvealmelanoma
AT huiliu highexpressionoflncrnapvt1independentlypredictspooroverallsurvivalinpatientswithprimaryuvealmelanoma